Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Class A Ordinary Shares
-
Shares outstanding
-
73,666,602
-
Total 13F shares
-
41,145,976
-
Share change
-
+5,803,272
-
Total reported value
-
$178,160,287
-
Put/Call ratio
-
248%
-
Price per share
-
$4.33
-
Number of holders
-
66
-
Value change
-
+$26,671,383
-
Number of buys
-
32
-
Number of sells
-
37
Institutional Holders of Zura Bio Ltd - Class A Ordinary Shares (ZURA) as of Q3 2025
As of 30 Sep 2025,
Zura Bio Ltd - Class A Ordinary Shares (ZURA) was held by
66 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
41,145,976 shares.
The largest 10 holders included
SUVRETTA CAPITAL MANAGEMENT, LLC, VR ADVISER, LLC, JPMORGAN CHASE & CO, GREAT POINT PARTNERS LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Pfizer Inc, BRAIDWELL LP, Ikarian Capital, LLC, ARMISTICE CAPITAL, LLC, and Affinity Asset Advisors, LLC.
This page lists
66
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.